KEMPHARM, INC Note Agreements
6 Contracts & Agreements
- Note Purchase Agreement dated as of August 30, 2023 by and among Zevra Therapeutics, Inc., and Nantahala Capital Management, LLC and the other sellers party thereto (Filed With SEC on August 31, 2023)
- Senior Secured Convertible Note, dated as of January 13, 2020 (Filed With SEC on January 13, 2020)
- Amendment to December 2019 Notes and Consent, dated as of January 12, 2020, by and among KemPharm, Inc. and the signatories party thereto (Filed With SEC on January 13, 2020)
- Form of Senior Secured Convertible Note, with a schedule of noteholders (Filed With SEC on December 18, 2019)
- Amended and Restated Senior Secured Convertible Note issued to Deerfield Private Design Fund III, L.P., dated as of December 18, 2019 (Filed With SEC on December 18, 2019)
- Facility Agreement Waiver and Fifth Amendment to Senior Secured Convertible Note by and between the Company and Deerfield Private Design Fund III, L.P., dated as of June 11, 2018 (Filed With SEC on June 11, 2018)
